Ascend Wellness Holdings (AAWH) Price to Sales (2021 - 2026)

Ascend Wellness Holdings has reported Price to Sales for 6 years, with the latest figure at 1.61 in Q2 2026.

• On a quarterly basis, Price to Sales rose 215.04% year-over-year to 1.61 in Q2 2026; TTM through Jun 2026 was 0.42, a 240.62% increase from a year earlier, with the FY2025 full-year figure at 0.29, up 107.12% from the prior year.
• Price to Sales was 1.61 for Q2 2026 at Ascend Wellness Holdings, up from 0.83 in the prior quarter.
• The five-year high for Price to Sales was 8.2 in Q1 2022, with the low at 0.51 in Q2 2025.
• Average Price to Sales over 5 years is 1.85, with a median of 1.37 recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Price to Sales tumbled 84.85% in 2022, then surged 215.04% in 2026.
• Over 5 years, Price to Sales stood at 1.93 in 2022, then fell by 23.5% to 1.48 in 2023, then slumped by 60.17% to 0.59 in 2024, then surged by 108.29% to 1.22 in 2025, then jumped by 31.47% to 1.61 in 2026.
• The last three Price to Sales figures came in at 1.61 (Q2 2026), 0.83 (Q1 2026), and 1.22 (Q4 2025), per Business Quant data.